Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.

MLA

Daneshdoost, Shanaz M., et al. “Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.” Journal of Pediatric Hematology/Oncology, vol. 43, no. 3, Apr. 2021, pp. e365–70. EBSCOhost, https://doi.org/10.1097/mph.0000000000001793.

APA

Daneshdoost, S. M., El Abiad, J. M., Ruble, K. J., Jones, L. C., Crane, J. L., Morris, C. D., & Levin, A. S. (2021). Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review. Journal of Pediatric Hematology/Oncology, 43(3), e365–e370. https://doi.org/10.1097/mph.0000000000001793

Chicago

Daneshdoost, Shanaz M., Jad M. El Abiad, Kathy J. Ruble, Lynne C. Jones, Janet L. Crane, Carol D. Morris, and Adam S. Levin. 2021. “Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.” Journal of Pediatric Hematology/Oncology 43 (3): e365–70. doi:10.1097/mph.0000000000001793.